工艺装备美国申请中

Crystalline pharmaceutical and methods of preparation and use thereof

Ask AI about this

查看原文 ↗

申请人Novartis Pharmaceuticals Corporation

发明人John Burnier

公开号US20230331711A1

申请日2023-06-20

公开日2023-10-19

摘要

Novel crystalline polymorphic forms, Forms A, B, C, D, and E of a compound of Formula I, which has been found to be a potent inhibitor of LFA-1, are disclosed. Methods of preparation and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed in this invention.

Crystalline pharmaceutical and methods of preparation and use thereof

摘要

相关专利